Jose S Duca

USPTO Granted Patents = 12 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 8 (Patent Applications = 3)

Average Co-Inventor Count = 11.5

ph-index = 3

Forward Citations = 26(Granted Patents)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

Years Active: 2009-2015

Loading Chart...

12 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9206142 - Anilinopiperazine derivatives and methods of use thereof (2015-12-08),

2. 8765757 - 3-heterocyclic substituted indole derivatives and methods of use thereof (2014-07-01),

3. 8614229 - Substituted indole derivatives and methods of use thereof (2013-12-24),

4. 8557848 - 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections (2013-10-15),

5. 8318735 - 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors (2012-11-27),

6. 8227605 - 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors (2012-07-24),

7. 8143305 - 2,3-substituted indole derivatives for treating viral infections (2012-03-27),

8. 8034907 - Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides (2011-10-11),

9. 7888474 - HDM2 polypeptides (2011-02-15),

10. 7705127 - HDM2 Polypeptides (2010-04-27),

11. 7632920 - Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof (2009-12-15),

12. 7511063 - High affinity quinoline-based kinase ligands (2009-03-31),

Title: The Innovative Contributions of Jose S Duca

Introduction

Jose S Duca, an accomplished inventor based in Cranford, NJ, has made significant strides in the field of pharmaceuticals with a total of 12 patents to his name. His work primarily focuses on developing novel compounds aimed at treating various medical conditions, highlighting his commitment to innovation in the healthcare sector.

Latest Patents

Among his latest patents, the invention of Anilinopiperazine derivatives stands out. This patent encompasses new derivatives of a specific chemical formula, aimed at treating or preventing a range of serious health issues including cancer, inflammatory conditions, and central nervous system disorders. Additionally, he has developed patentable 3-heterocyclic substituted indole derivatives. These compounds are designed for utilization in treating viral infections and related disorders, showcasing his versatility in tackling diverse health challenges.

Career Highlights

Jose S Duca's career is marked by his association with reputable organizations such as Schering Corporation and Merck Sharp & Dohme Corporation. His experiences in these companies not only enriched his professional background but also provided him with a platform to enhance his research and development capabilities, further solidifying his role as a key player in drug innovation.

Collaborations

Throughout his career, Jose has collaborated with notable colleagues including Gerald Wayne Shipps, Jr. and Vincent Stewart Madison. These collaborations have likely contributed to his innovative approach and success in developing impactful medical therapies.

Conclusion

Jose S Duca exemplifies the spirit of innovation within the pharmaceutical industry. His patents reflect a dedication to addressing significant health issues through inventive solutions. As he continues to expand his contributions to medical science, his work remains a valuable asset to both the research community and the patients who may benefit from his developments.

This text is generated by artificial intelligence and may not be accurate.